Axplora

Lyon, France Founded: 1995 • Age: 31 yrs Acquired By BNP Paribas
Innovative API manufacturing solutions are provided by Axplora globally.

About Axplora

Axplora is a Healthcare company based in Lyon (France) founded in 1995, and was acquired by BNP Paribas in November 2006. Innovative API manufacturing solutions are provided by Axplora globally. It operates on a Professional Services model in Healthcare and Industrial Goods & Manufacturing sectors. Axplora has raised $3.97 million across 2 funding rounds from investors including BNP Paribas, Azulis Capital and Banexi Capital Partenaires. Its chief executive, as recorded, is Pierre Lunel. Axplora offers products and services including API Manufacturing, ADC Manufacturing, and HPAPI Manufacturing. Its focus areas include Pharmaceuticals and Active Pharmaceutical Ingredients. Its legal entity is Axplora Group GmbH.

Company details

Axplora is engaged in the development and manufacturing of active pharmaceutical ingredients (APIs) and advanced therapies like antibody-drug conjugates (ADCs) for the pharmaceutical industry. Operating across Europe, India, and the US, the company serves over 900 customers and benefits millions of patients worldwide. Specialized services include API development, HPAPI manufacturing, and technologies such as chromatography and flow chemistry. Sectors covered include oncology and metabolic disorders, with a focus on sustainable and technologically advanced solutions.

  • Headquarters Lyon, France
  • Stage Acquired
  • Sectors
    Healthcare
    Industrial Goods & Manufacturing
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website novasep.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Acquired by BNP Paribas (Nov 2006)
  • Legal Name Axplora Group Gmbh
Key Metrics
  • Total Equity Funding
    $3.97M (USD)

    in 2 rounds

  • Latest Funding Round
    $314.81K (USD), Grant

    Feb 2019

  • Investors
  • Acquired by
    BNP Paribas

    (Nov 2006)

Products & Services of Axplora

Axplora offers a comprehensive portfolio of products and services, including API Manufacturing, ADC Manufacturing, and HPAPI Manufacturing.

API Manufacturing
Pharmaceuticals

Active pharmaceutical ingredients are manufactured for global clients.

ADC Manufacturing
Pharmaceuticals

Antibody-drug conjugates are produced for oncology treatments.

HPAPI Manufacturing
Pharmaceuticals

Highly potent APIs are developed for specialized drugs.

Apps and channels of Axplora

its YouTube channel Axplora has 122 subscribers and 17 videos.

Axplora
YouTube 122 subscribers 17 videos Science & Technology
Open channel

Videos from Axplora

The most watched videos on Axplora's YouTube channel, Axplora (122 subscribers). Click a video to play it here.

Talenrama #2 Axplora Le Mans
5.7K views
Axplora Origins: three legacies, one company
1.2K views
Talenrama #3 Axplora Le Mans (Fr)
796 views
Axplora Is Born
657 views

More on Axplora.

Funding Insights of Axplora

Axplora has successfully raised a total of $3.97M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $314.81 thousand completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.97M
  • Total Rounds 2
  • Last Round Grant — $314,812
  • First Round $3.97M

    (Mar 2012)

  • Investors Count 1

All 2 funding rounds of Axplora with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2019$314,812Grant––
–
Mar 2012$3.97MSeries A––
Valuation history

4 investors in total: 4 institutional.

Investors in Axplora

Axplora has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include BNP Paribas, Azulis Capital and Banexi Capital Partenaires.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity fund focused on health care, food and beverages, consumers, and multiple sectors
azuliscapital.frParis, France
Private equity and accelerator investments are directed toward multiple sectors.
riveancapital.comBrussels, Belgium
Banking & financial service provider
1848group.bnpparibasParis, France
banexicapital.com
Premium access

Investor details for Axplora

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Axplora

1 people are tracked at Axplora (1 in leadership).

NameRoleGroup
Pierre Lunel
CEOLeadership
Premium access

Complete people profiles for Axplora

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Axplora

4 dated milestones of Axplora across 24 years, from founding to its latest funding, stage changes and deals.

  1. Founded Axplora is founded.
  2. Exit Acquired by BNP Paribas.
  3. Funding First funding round of $4.0M.
  4. Funding Latest funding round, Grant, of $315K.

Web traffic of Axplora

Websites that share an audience with Axplora (novasep.com).

Similar websites

Websites whose visitors overlap most with Axplora. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
thefluoroprobe.com
thefluoroprobe.com
100%
–
autodialers-usa.com
autodialers-usa.com
100%
–
attitudetechnology.com
attitudetechnology.com
100%
–
stest.co.uk
stest.co.uk
100%
–
dimanco.com
dimanco.com
100%
–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 20 similar websites and full traffic analytics for Axplora

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 20 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Axplora

Premium access

Complete news archive for Axplora

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Axplora

Axplora was founded in 1995 and raised its 1st funding round 17 years after it was founded.

Axplora is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.

Pierre Lunel is the CEO of Axplora, as recorded in our data.

Axplora is a funded company, having raised a total of $3.97M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.97M, raised on Mar 2012.

Axplora is engaged in the development and manufacturing of active pharmaceutical ingredients (APIs) and advanced therapies like antibody-drug conjugates (ADCs) for the pharmaceutical industry. Operating across Europe, India, and the US, the company serves over 900 customers and benefits millions of patients worldwide. Specialized services include API development, HPAPI manufacturing, and technologies such as chromatography and flow chemistry. Sectors covered include oncology and metabolic disorders, with a focus on sustainable and technologically advanced solutions.

Axplora offers API Manufacturing, ADC Manufacturing, and HPAPI Manufacturing.

Axplora has 4 investors. Key investors include BNP Paribas, Azulis Capital, Banexi Capital Partenaires, and Rivean Capital.

Axplora operates through Axplora Group Gmbh.

Yes. Axplora was acquired by BNP Paribas in November 2006.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available